SCHAFER CULLEN CAPITAL MANAGEMENT INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 816 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
SCHAFER CULLEN CAPITAL MANAGEMENT INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q1 2021$12,825,000
-93.5%
150,035
-92.8%
2.61%
-10.8%
Q4 2020$197,645,000
+1.1%
2,093,030
-6.9%
2.93%
-4.6%
Q3 2020$195,412,000
-3.8%
2,247,149
-3.4%
3.07%
-1.9%
Q2 2020$203,160,000
+0.0%
2,326,084
-5.6%
3.13%
-7.9%
Q1 2020$203,097,000
-17.2%
2,463,279
-4.9%
3.40%
+18.0%
Q4 2019$245,376,000
+5.6%
2,591,364
-3.1%
2.88%
+3.0%
Q3 2019$232,276,000
-5.1%
2,672,913
-3.7%
2.80%
-2.8%
Q2 2019$244,838,000
+13.5%
2,776,261
+23.8%
2.88%
-8.9%
Q1 2019$215,631,000
+4.9%
2,242,885
-6.4%
3.16%
-0.3%
Q4 2018$205,517,000
-8.3%
2,395,023
-7.9%
3.17%
+8.8%
Q3 2018$224,085,000
+15.2%
2,600,805
+1.0%
2.91%
+16.0%
Q2 2018$194,457,000
-10.3%
2,574,227
-4.0%
2.51%
-3.6%
Q1 2018$216,807,000
-2.0%
2,681,593
+1.7%
2.60%
+1.2%
Q4 2017$221,323,000
-2.5%
2,636,058
-0.3%
2.57%
-5.8%
Q3 2017$226,985,000
-2.2%
2,643,971
-4.9%
2.73%
-5.4%
Q2 2017$232,097,000
+22.7%
2,780,606
+9.2%
2.89%
+18.8%
Q1 2017$189,189,000
+11.2%
2,547,314
+9.1%
2.43%
+5.4%
Q4 2016$170,103,000
+52.5%
2,335,291
+65.3%
2.31%
+71.8%
Q3 2016$111,544,000
+0.4%
1,412,668
+4.9%
1.34%
-0.6%
Q2 2016$111,114,000
+15.3%
1,346,669
+1.2%
1.35%
+14.4%
Q1 2016$96,358,000
-17.9%
1,330,183
-2.5%
1.18%
-15.5%
Q4 2015$117,436,000
-18.0%
1,364,900
-12.4%
1.40%
-15.0%
Q3 2015$143,187,000
-7.8%
1,557,738
-1.4%
1.64%
+2.4%
Q2 2015$155,337,000
-5.5%
1,579,591
-5.2%
1.60%
-1.4%
Q1 2015$164,329,000
+64.1%
1,666,457
+54.2%
1.63%
+28.4%
Q4 2014$100,118,000
-41.6%
1,080,490
-40.6%
1.27%
-22.5%
Q3 2014$171,302,000
+4.3%
1,819,842
+0.3%
1.64%
+8.1%
Q2 2014$164,262,000
+5.6%
1,814,449
-0.9%
1.51%
+0.3%
Q1 2014$155,598,000
+13.6%
1,830,137
+7.4%
1.51%
+11.4%
Q4 2013$136,953,000
+16.8%
1,703,817
+11.5%
1.36%
+5.0%
Q3 2013$117,245,000
+26.5%
1,528,414
+16.6%
1.29%
+16.6%
Q2 2013$92,700,0001,310,9871.11%
Other shareholders
NOVARTIS A G shareholders Q4 2013
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 332,962$27,452,0007.32%
Mawer Investment Management Ltd. 7,721,327$636,623,0005.86%
Martin Investment Management, LLC 133,246$10,986,0005.56%
SCHARF INVESTMENTS, LLC 1,330,175$109,673,0005.48%
Hansberger Growth Investors, LP 46,663$3,847,0005.19%
Bain Capital Public Equity Management II, LLC 440,233$36,297,0004.25%
First Fiduciary Investment Counsel, Inc. 187,633$15,470,0004.10%
GARLAND CAPITAL MANAGEMENT INC 53,555$4,416,0004.02%
Lowell Blake & Associates Inc. 37,219$3,069,0003.94%
PRENTISS SMITH & CO INC 68,027$5,609,0003.89%
View complete list of NOVARTIS A G shareholders